OT on Instagram

Ophthalmologists called upon to help impaired colleaguesOphthalmologists must take an active role in preventing impaired colleagues from hurting patients, according to Terri Pickering, MD.
How advances in phaco benefit glaucoma surgeryAdvances in phacoemulsification are creating new opportunities for glaucoma surgery, especially in developing countries, according to Alan S. Crandall, MD.
Vitrectomy offers a viable therapeutic option for DMEMaurice B. Landers III, MD, presents an argument that in an era when pharmacological therapy has become the mainstay for the treatment of diabetic macular edema (DME), pars plana vitrectomy (PPV) deserves consideration as a reasonable alternative for early DME in appropriate patients.
Virtual reality on the horizon for treatment of glaucomaOne laboratory is at work on new devices that use visual stimuli to prompt retinal ganglion cells to regenerate, while two other researchers describe techniques through which virtual reality might diagnose the disease more accurately than standard automated perimetry.
Investigating strains on ONH tissue key to unraveling mystery of glaucomaInvestigations of the biomechanical changes in the optic nerve head may eventually lead to improvements in therapies for patients with glaucoma.
Are you aware of the available resources for AMD?Since February is designated Age-Related Macular Degeneration Awareness month. For healthcare providers, there are numerous resources available to help promote awareness to patients and to encourage patients to continue (or start) annual visual exams.
Video system has ‘transformative potential’ for blind patients
Research offers insights on clinical course, management of CSCR
Novel IOL may be key to preventing negative dysphotopsia
Treat-and-extend protocol reduces burden of anti-VEGF treatment for DMEResults of the prospective TREX-DME study provide an evidence base for using a treat-and-extend protocol for administering anti-VEGF injections for eyes with diabetic macular edema.